Does the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent improve efficacy compared to the EXPRESS stent?
The paclitaxel-eluting TAXUS stent demonstrates sustained and increasing efficacy at 1 year compared to the EXPRESS stent, with no apparent safety concerns.
The relative efficacy reported at 9 months for the polymer-based, paclitaxel-eluting TAXUS stent compared with the EXPRESS stent is preserved and continues to increase at 1 year, with no safety concerns apparent.
Stone et al. (Tue,) studied this question.